We are thrilled to announce that Remap Consulting will be attending the World Evidence, Pricing and Access Congress (World EPA) in Amsterdam on March 3-4, 2026. World EPA is a leading event for health economics and market access professionals, bringing together global experts to discuss key topics such as HTA, market access, rare diseases, reimbursement, and real-world evidence (RWE). We look forward to engaging discussions, thought-provoking presentations, and connecting with industry leaders to explore how we can help overcome challenges and optimize market access strategies.
Visit us at Stand 400A
Attending:
Poster presentation
Private vs Public Access – Exploring how GLP-1s may influence treatment pathways and patient behaviour
Presentation
HTA Session
Speaker: Paul Craddy
3 March | 12:20 pm
If you’re attending World EPA, please do stop by our stand, attend our session, or simply come and say hello — we’d love to connect in person.